American International Group’s Enzo Biochem, Inc. ENZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-25,891
| Closed | -$89 | – | 3296 |
|
|
2021
Q1 | $89 | Buy |
25,891
+69
| +0.3% | +$215 | ﹤0.01% | 2774 |
|
|
2020
Q4 | $65 | Sell |
25,822
-741
| -3% | -$1.61K | ﹤0.01% | 2868 |
|
|
2020
Q3 | $56K | Sell |
26,563
-605
| -2% | -$1.44K | ﹤0.01% | 2844 |
|
|
2020
Q2 | $61K | Buy |
27,168
+1,044
| +4% | +$2.68K | ﹤0.01% | 2810 |
|
|
2020
Q1 | $66K | Sell |
26,124
-1,509
| -5% | -$3.71K | ﹤0.01% | 2550 |
|
|
2019
Q4 | $73K | Sell |
27,633
-232
| -0.8% | -$693 | ﹤0.01% | 2768 |
|
|
2019
Q3 | $100K | Sell |
27,865
-194
| -0.7% | -$687 | ﹤0.01% | 2611 |
|
|
2019
Q2 | $95K | Sell |
28,059
-25
| -0.1% | -$88 | ﹤0.01% | 2707 |
|
|
2019
Q1 | $77K | Sell |
28,084
-910
| -3% | -$2.98K | ﹤0.01% | 2733 |
|
|
2018
Q4 | $81K | Sell |
28,994
-222
| -0.8% | -$727 | ﹤0.01% | 2700 |
|
|
2018
Q3 | $120K | Buy |
29,216
+525
| +2% | +$2.38K | ﹤0.01% | 2725 |
|
|
2018
Q2 | $149K | Buy |
28,691
+555
| +2% | +$3.38K | ﹤0.01% | 2543 |
|
|
2018
Q1 | $154K | Buy |
28,136
+393
| +1% | +$2.77K | ﹤0.01% | 2414 |
|
|
2017
Q4 | $226K | Buy |
27,743
+131
| +0.5% | +$1.25K | ﹤0.01% | 2254 |
|
|
2017
Q3 | $289K | Buy |
27,612
+2,064
| +8% | +$22.9K | ﹤0.01% | 2072 |
|
|
2017
Q2 | $282K | Buy |
25,548
+1,116
| +5% | +$10.4K | ﹤0.01% | 2066 |
|
|
2017
Q1 | $204K | Buy |
24,432
+1,610
| +7% | +$11.3K | ﹤0.01% | 2173 |
|
|
2016
Q4 | $158K | Sell |
22,822
-59
| -0.3% | -$377 | ﹤0.01% | 2333 |
|
|
2016
Q3 | $116K | Buy |
22,881
+35
| +0.2% | +$209 | ﹤0.01% | 2512 |
|
|
2016
Q2 | $136K | Buy |
22,846
+21,846
| +2,185% | +$121K | ﹤0.01% | 2393 |
|
|
2016
Q1 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 4744 |
|
|
2015
Q4 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 4707 |
|
|
2015
Q3 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 4771 |
|
|
2015
Q2 | $3.03K | Sell |
1,000
-21,510
| -96% | -$60.5K | ﹤0.01% | 4838 |
|
|
2015
Q1 | $66.4K | Hold |
22,510
| – | – | ﹤0.01% | 3820 |
|
|
2014
Q4 | $99.9K | Sell |
22,510
-826
| -4% | -$3.94K | ﹤0.01% | 3584 |
|
|
2014
Q3 | $120K | Sell |
23,336
-142
| -0.6% | -$758 | ﹤0.01% | 3408 |
|
|
2014
Q2 | $123K | Buy |
23,478
+22,478
| +2,248% | +$97.2K | ﹤0.01% | 3425 |
|
|
2014
Q1 | $4.16K | Hold |
1,000
| – | – | ﹤0.01% | 4583 |
|
|
2013
Q4 | $2.92K | Hold |
1,000
| – | – | ﹤0.01% | 4561 |
|
|
2013
Q3 | $2.52K | Sell |
1,000
-2,907
| -74% | -$6.89K | ﹤0.01% | 4495 |
|
|
2013
Q2 | $8.13K | Buy |
+3,907
| New | +$8.62K | ﹤0.01% | 4184 |
|
Other funds holding ENZ
HFA
RAM
EGA
VCA
American International Group's ENZ Position: Q2 2021 in Review
American International Group sold out of Enzo Biochem, Inc. (ENZ) in Q2 2021, closing a stake of 25,891 shares — an estimated $89 sold.
American International Group first reported a position in ENZ in Q2 2013 and held it in 32 quarters. The position peaked at $289K in Q3 2017. 72 funds tracked by Wall St. Rank hold ENZ as of Q2 2021.
- American International Group reported no remaining Enzo Biochem, Inc. position as of Q2 2021 after selling out during the quarter.
- American International Group sold 25,891 Enzo Biochem, Inc. shares in Q2 2021, an estimated $89.
- American International Group first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 32 quarters.
- American International Group's Enzo Biochem, Inc. position peaked at $289K in Q3 2017.
- 72 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q2 2021.
Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.